Delivery Order SPE2DB22D3301-SPE2DB25FY6HF
- Not listed
- The Defense Logistics Agency awarded a $4,057.92 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price contract, with completion targeted for September 10, 2025, represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. Valued at $5,410.56 with a firm fixed price structure, this non-set-aside delivery order represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a $4,997.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml contrast medium in 100ml infusion bottles. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive set-aside delivery order for medical imaging supplies. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a $1,582.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 180 mg/mL vials (10 mL units) on August 20, 2025, with a completion date of August 21, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- The Defense Logistics Agency awarded a $1,171.00 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Omnipaque 300 mg/mL contrast medium in 100 mL infusion bottles. This non-set-aside, firm fixed price delivery order is scheduled for completion by June 3, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the company's broader relationship with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,352.64 for Omnipaque 350 mg/ml Pluspak 500ml, a contrast agent used in diagnostic imaging procedures. The contract is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,381.60 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml, a contrast media pharmaceutical product in 500ml Pluspak packaging. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Omnipaque 300 mg/mL infusion bottles (100 mL units) under a firm fixed-price contract valued at $2,183.45. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 9, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Omnipaque 180 mg/mL vials (10 mL units) with a ceiling value of $3,890.53. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by July 14, 2025, with performance at AmerisourceBergen's corporate...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY6HFDelivery Order
The Defense Logistics Agency awarded a $3,043.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500ml, a contrast medium used in medical imaging procedures. This is a non-set-aside, competitively awarded contract with a completion date of June 17, 2025, and performance executed from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The vendor maintains an extensive portfolio of pharmaceutical and medical supply deliveries through the DLA Medical Supply Chain, with delivery orders utilizing firm fixed pricing across a wide range of therapeutic domains. As the prime contractor under the SPE2DX global pharmaceutical support vehicle, AmerisourceBergen supplies pharmaceutical products and medical commodities including specialty medications, vaccines, and medical devices to support Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 6/16/25 |